Quick Answer
Journey Medical Corp reported Diluted EPS of $0.47 per share (loss) for fiscal year 2025.
Journey Medical Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.47 | +34.7% |
| 2024 | -$0.72 | -242.9% |
| 2023 | -$0.21 | +87.6% |
| 2022 | -$1.69 | +60.9% |
| 2021 | -$4.32 | -981.6% |
| 2020 | $0.49 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.09 | +25.0% | +43.8% |
| June 30, 2025 | -$0.16 | +5.9% | +11.1% |
| March 31, 2025 | -$0.18 | +66.0% | -50.0% |
| September 30, 2024 | -$0.12 | -115.0% | +29.4% |
| June 30, 2024 | -$0.17 | +63.0% | +67.9% |
| March 31, 2024 | -$0.53 | +7.0% | -166.2% |
| September 30, 2023 | $0.80 | +240.4% | +273.9% |
| June 30, 2023 | -$0.46 | -7.0% | +19.3% |
- Journey Medical Corp showed an increase of +34.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Journey Medical Corp’s diluted eps has declined by 195.9% (from $0.49 per share to $0.47 per share (loss)).
- The most recent figure is from Journey Medical Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: